clinical trial Archive — Page 3 of 16

Transparent glass sphere over concentric circular patterns, creating a blue-toned optical illusion with the rings magnified and distorted through the sphere.
December 2, 2025

Study seeks to determine best way to treat myopia in children

Researchers hope to slow the progression of this chronic eye disease that affects approximately 40% of the U.S. population.

By Jessica Pasley
3D illustration of a blood clot lodged inside a blood vessel, partially blocking the flow of red blood cells.
November 11, 2025

AI recruited to lower leading cause of preventable hospital deaths

Risk of VTE rises in hospitals due to factors such as patient immobility, effects from major surgery, and use of indwelling medical devices like central lines.

By Paul Govern
(iStock image)
November 4, 2025

VUMC performs minimally invasive transcatheter tricuspid valve replacement for recent heart transplant recipient

The team used an artificial tricuspid valve, EVOQUE, which received Food and Drug Administration approval in February.

By Jill Clendening
Julia Sheffield, PhD, smiles while seated at a desk beside a computer monitor, telephone, coffee mug, houseplants, and a stained-glass lamp.
October 22, 2025

Behind the curtain: Secrets of the volatile, delusional brain 

The VUMC approach, based on the “Feeling Safe Program” developed by British psychologist Daniel Freeman, targets specific factors that contribute to persecutory delusions, including worry, safety behaviors, avoidance and hallucinations (such as hearing voices).

By Bill Snyder
Amber-colored softgel capsules arranged in a large letter-shaped oval on a dark gray background.
September 12, 2025

Study shows magnesium inhibits colorectal cancer carcinogenesis by increasing vitamin D-synthesizing bacteria  

The findings from the current study suggest that magnesium also increases the gut synthesis of vitamin D, which does not go to the blood and takes effect locally.

By Tom Wilemon
Stylized blue-and-orange medical illustration of two kidneys with branching blood vessels, surrounded by floating particle-like forms.
August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

By Leigh MacMillan